Skip to content

Author

R. de Caterina

We have 6 of 1,275 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

Prediabetes is a clinically relevant cardiometabolic state and its role as an independent CV therapeutic target remains uncertain, but future trials should address phenotype-specific risk stratification and evaluate contemporary cardiometabolic therapies in appropriately powered populations.

F. Biondi, S. Ghelardoni, E. Monti et al. · 0 citations
Review Sep 2026

Emerging Longer-Term Evidence on Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in Low-Risk Patients: A Call for Caution.

The expanding use of transcatheter aortic valve implantation (TAVI) in low-risk patients with severe aortic stenosis, including populations underrepresented in pivotal trials and often beyond established guideline recommendations, makes extended follow-up from TAVI versus surgical aortic valve replacement (SAVR) trials...

M. Sousa Uva, Milan Milojevic, M. Marín-Cuartas et al. · 0 citations
Open access Aug 2026

Impact of CYP2C19 loss-of-function variants on outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and study design of the WOEST-3 genetic substudy

The rationale and design of a genetic substudy aimed at clarifying the prognostic relevance of CYP2C19 genotype in AF patients undergoing PCI and informing the design of future genotype-guided antithrombotic trials are described.

S. Chiusolo, A. Verburg, C. Morizzo et al. · 0 citations
Open access Aug 2026

Visual standardized quantification of late gadolinium enhancement, a contour-less method for late gadolinium enhancement quantification

VISTAQ provides highly reproducible, time-efficient LGE quantification without dedicated software and demonstrates non-inferior prognostic discrimination in HCM compared with conventional threshold-based techniques.

G. D. Aquaro, R. Licordari, C. De Gori et al. · 0 citations
Aug 2026

The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification.

Advanced diagnostic testing was associated with a higher likelihood of a determined etiologic diagnosis in MINOCA, despite marked international variability in its use; however, this association is partly definitional, as advanced testing directly contributes to diagnostic ascertainment for several etiologic categories.

D. Morrone, M. Alberti, J. Cravo et al. · 0 citations
Open access Jul 2026

Standard clinical and stress electrocardiogram variables to exclude left main and left main-equivalent disease: the MASTER study.

Among CCS patients, LMCAD/LMCAD-equivalent can be excluded with high negative predictive value through a model based on clinical and EST parameters, allowing initial non-invasive management of most patients able to exercise.

M. D. De Carlo, M. A. Malanima, L. Baglietto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.